Literature DB >> 16950017

Chapter 5: Updating the natural history of HPV and anogenital cancer.

Anna-Barbara Moscicki1, Mark Schiffman, Susanne Kjaer, Luisa L Villa.   

Abstract

The major steps in cervical carcinogenesis include infection of the metaplastic epithelium of the cervical transformation zone with one or more of the 12-18 carcinogenic types of human papillomavirus (HPV) infection, viral persistence, clonal progression of the persistently-infected epithelium to cervical precancer, and invasion. Although these fundamental steps are established, several new epidemiologic studies have shed light on the factors that influence each of these transitions. The importance of the transformation zone in cervical cancer has been extended to other HPV-induced cancers such as anal or tonsillar cancers. Natural history studies show that HPV with normal cervical cytology and cervical intraepithelial neoplasia (CIN) grade 1 behave similarly, with the majority of both showing regression. Although these studies have demonstrated the importance of HPV persistence in the development of precancer CIN-3, the timing from infection to evidence of CIN-3 varies from 1 to 10 years. Whether equivalent lesions diagnosed later differ in their natural history remains unknown. Several factors have been implicated in enhancing persistence and/or progression. However, none are consistently associated with both except age: young women are less likely to show persistence and older women with persistence are more likely to be at risk of invasive cancer. Recent studies have also underscored the importance of the host immune response in clearance of established infections. Finally, data on non-cervical HPV infections, such as penile infections are limited to date compared to cervical infections. Several ongoing cohort studies should give us further insight into male infections in the near future.

Entities:  

Mesh:

Year:  2006        PMID: 16950017     DOI: 10.1016/j.vaccine.2006.06.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  130 in total

1.  Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Stephen Cherne; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-20       Impact factor: 4.254

Review 2.  Multidisciplinary Approach to the Management and Treatment of Anal Dysplasia.

Authors:  Jeffrey Douaiher; Sean J Langenfeld
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

3.  Prevalence of Anal HPV and Anal Dysplasia in HIV-Infected Women From Johannesburg, South Africa.

Authors:  Bridgette J Goeieman; Cynthia S Firnhaber; Eefje Jong; Pam Michelow; Patricia Kegorilwe; Avril Swarts; Anna-Lise Williamson; Bruce Allan; Jennifer S Smith; Timothy J Wilkin
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

4.  Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106.

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Robert D Burk
Journal:  J Gen Virol       Date:  2007-11       Impact factor: 3.891

Review 5.  Conservative management of adolescents with abnormal cytology and histology.

Authors:  Anna-Barbara Moscicki
Journal:  J Natl Compr Canc Netw       Date:  2008-01       Impact factor: 11.908

Review 6.  Human papillomavirus vaccines launch a new era in cervical cancer prevention.

Authors:  Meenakshi Dawar; Shelley Deeks; Simon Dobson
Journal:  CMAJ       Date:  2007-08-28       Impact factor: 8.262

7.  The human papillomavirus vaccine: The promise of cervical cancer prevention.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

8.  Retrospective analysis of HPV 16/18-related disease burden using archival clinical samples.

Authors:  Naureen Ehsan Ilahi; Shoaib Naiyar Hashmi; Sobia Anwar; Sheeba Murad
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

9.  Human papillomavirus infection in women in Puerto Rico: agreement between physician-collected and self-collected anogenital specimens.

Authors:  Ana Patricia Ortiz; Josefina Romaguera; Cynthia M Pérez; Yomayra Otero; Marievelisse Soto-Salgado; Keimari Méndez; Yari Valle; Maria Da Costa; Erick Suarez; Joel Palefsky; Guillermo Tortolero-Luna
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

10.  Prevalence of human papillomavirus in university young women.

Authors:  Maria T Montalvo; Ismelda Lobato; Hilda Villanueva; Celia Borquez; Daniela Navarrete; Juan Abarca; Gloria M Calaf
Journal:  Oncol Lett       Date:  2011-04-06       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.